Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Ledipasvir

SKU: orb1223362

Description

Ledipasvir, also known as GS-5885; is an inhibitor of the hepatitis C virus NS5A protein and is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. On October 10, 2014 the FDA approved the combination product ledipasvir 90 mg/sofosbuvir 400 mg (trade name Harvoni). The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin.

Research Area

Pharmacology & Drug Discovery

Images & Validation

−
Ledipasvir

Key Properties

−
CAS Number1256388-51-8
MW889
Purity>98% (HPLC)
FormulaC49H54F2N8O6
SMILESO=C(OC)N[C@H](C(=O)N1[C@H](c2ncc(c3cc4C(F)(F)c5c(ccc(c6ccc7nc([C@H]8N(C(=O)[C@@H](NC(=O)OC)C(C)C)[C@@H]9CC[C@H]8C9)[nH]c7c6)c5)c4cc3)[nH]2)CC2(C1)CC2)C(C)C
TargetHDAC
SolubilityDMSO : 50 mg/mL. 56.24 mM;H2O : < 0.1 mg/mL

Bioactivity

−
In Vivo
Ledipasvir is remarkable not only on the basis of its high replicon potency but also on the basis of its low clearance, good bioavailability, and long half-lives in rat, dog, and monkey and low predicted clearance in human. The pharmacokinetics of Ledipasvir is measured in rats and dogs. Ledipasvir shows good half-lives (rat 1.83 ± 0.22 hr, dog 2.63 ± 0.18 hr) in plasma, low systemic clearance (CL), and moderate volumes of distribution (Vss) that are greater than total body water volume.
In Vitro
Ledipasvir has GT1a and 1b EC50 values of 31 and 4 pM, respectively, and protein-adjusted EC50 values of 210 pM (GT1a) and 27 pM (GT1b) and the intrinsic EC50 of 39 is 310 fM for GT1a and 40 fM for GT1b. Ledipasvir is highly protein-bound both in human serum and in the cell-culture medium (containing 10% BSA) of the replicon assay. Ledipasvir exhibits an EC50 value of 141 nM against the JFH/3a-NS5A replicon.

Storage & Handling

−
StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

−
GS5885 | GS-5885 | GS 5885 | Ledipasvir

Similar Products

−

  • Ledipasvir impurity 55 [orb3181546]

    1499193-60-0

    407

    C13H6BrF2I

    50 mg, 10 mg

  • Ledipasvir impurity 53 [orb3181490]

    1129634-43-0

    255.31

    C13H21NO4

    10 mg, 50 mg

  • Ledipasvir (acetone) [orb1303066]

    100.00% (May vary between batches)

    1441674-54-9

    947.08

    C52H60F2N8O7

    2 mg, 5 mg, 10 mg, 50 mg, 1 mg, 25 mg, 1 ml x 10 mM (in DMSO)

  • Ledipasvir-d6 [orb2280893]

    895.04

    C49H48D6F2N8O6

    5 mg, 1 mg

  • Ledipasvir hydrochloride [orb1982181]

    2128695-48-5

    925.46

    C49H55ClF2N8O6

    50 mg, 100 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol
HDAC

Protocol Information

Find More Protocols

Available Sizes

Select a size below

1 g
Enquire
2 mg
$ 90.00
5 mg
$ 130.00
10 mg
$ 160.00
25 mg
$ 270.00
50 mg
$ 430.00
100 mg
$ 730.00
500 mg
$ 1,650.00
Bulk Enquiry
Need technical support? Find your Distributor Return and Tax Policy

Email

[email protected]

UK Office

+44 (0)1223 859353

US Office

+1 (415) 906-5211

CN Office

+86 (27)-87663101

Distributors

biorbyt.com/distributor